Vanguard Global Advisers
IBIO icon

Vanguard Global Advisers’s iBio IBIO Stock Holding History

Vanguard Global Advisers’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.55K Hold
5,460
– – ﹤0.01% 3485
2026
Q1 		$10.4K Buy
+5,460
New +$12.7K ﹤0.01% 3469

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Global Advisers's IBIO Position: Q2 2026 in Review

Vanguard Global Advisers held its iBio (IBIO) position steady in Q2 2026 at 5,460 shares worth $9.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Vanguard Global Advisers first reported a position in IBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.4K in Q1 2026. 51 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Vanguard Global Advisers held 5,460 shares of iBio worth $9.55K as of Q2 2026.
  • Vanguard Global Advisers left its iBio share count unchanged in Q2 2026.
  • iBio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3485 holding.
  • Vanguard Global Advisers first reported a position in iBio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's iBio position peaked at $10.4K in Q1 2026.
  • 51 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.